[ID] => 11202
[post_author] => 6150
[post_date] => 2019-07-04 14:46:25
[post_date_gmt] => 2019-07-04 13:46:25
[post_content] => Following disciplined procedures in cold chain logistics is critical to the storage and transport of pharmaceuticals. The slightest temperature variation can cause medications to lose their effectiveness or even become lethal to those that need them most.
It is frequently the distances between manufacturing site, intermediate storage and the destination that cause problems: the longer the goods are outside a regulated environment, the greater the risk that something will go wrong. To ensure the quality of produce is maintained during variable periods of storage and when in transport, DHL Supply Chain has now invested $150m in expanding its pharmaceutical and medical device distribution network in the US to reduce distances and improve services to customers across the nation.
That investment includes new buildings and technology, plus the fitting of equipment and start-up requirements of new or expanded operations. The plan is for nine new sites to be operational by the end of 2019, bringing critical healthcare products closer to trade partners and patients.
These nine new sites are strategically located across the US and are fully licensed with temperature-controlled spaces to support pharmaceutical storage requirements. Furthermore, the sites allow for packaging and managed transport for integrated solutions, adding another level of diversity in solutions for clients. Customers can now take advantage of a greater range of ambient and temperature-controlled facilities for single- and multi-location storage and inventory management requirements.
“This expansion allows DHL Supply Chain to continue to deepen the connections between our customers and the patients they serve,” says Scott Cubbler, president of life sciences and healthcare at DHL Supply Chain. “This most recent expansion also helps us leverage differentiated routes to market, driving even greater efficiency and productivity across the supply chain for our customers. With this expansion, DHL Supply Chain will have a total of 30 sites designed to support pharmaceutical, biotech and medical device companies.”
DHL Supply Chain has many years of experience handling pharmaceuticals and has worked diligently to create a network of compliant warehouses and vehicles. At these cold chain warehouse, packaging and shipment preparation areas are set up within the same protected environment, using innovative packaging materials to ensure the product temperature stays in the specified range, from the moment it leaves the warehouse until the time it arrives at the destination.
In a separate development, DHL Global Forwarding is expanding its capabilities at its Chicago warehouse located at O’Hare airport, with a portfolio of new services and technologies to support the company’s key growth sectors, particularly for life sciences and healthcare logistics, that was completed in June this year. As with the aforementioned projects at locations across the US, the O’Hare warehouse has been equipped a new temperature management import and export solution. This installation for life sciences and healthcare customers includes DHL SmartSensors that ensure temperature-sensitive shipments are monitored throughout the transport process, helping reduce demurrage costs.
The warehouse has also had an RFID passive and active tracking system installed. The new RFID tag technology provides the facility with the ability to detect where a container is from the moment it arrives at the 40,000-m2
warehouse to the moment it leaves, without the need for manual scanning.
“By making digitalisation and automation a priority, we recognise that we can deliver meaningful service and productivity improvements to our customers,” says David Goldberg, CEO at DHL Global Forwarding. “These new services meet our customers’ needs including better and quicker visibility on rates and routes, more responsiveness from their transportation providers and the knowledge that their shipments are secure. This is particularly important to industry sectors such as life sciences and healthcare, which have highly sophisticated and specialised requirements.”
Christopher Gonsowski, station manager at DHL Global Forwarding, Chicago, adds: “Few freight forwarders have this type of technology in place; meanwhile, DHL Global Forwarding is using it to manage all of its Chicago warehouse cargo inventory. The RFID passive and active technology will help us eliminate manual processes, reduce costs and time in our warehouse and respond more quickly to any exceptions in the transport process.”
Inaugurated in 2015, the O’Hare facility was the first DHL Global Forwarding facility in the US to become an IATA CEIV Pharma Certified Life Science Competence Centre.
The newly updated DHL SmartSensor temperature data logger, part of DHL Global Forwarding’s prioritisation of digitised and automated systems, provides distribution temperature control for the pharmaceutical and life sciences sectors. Using Near Field Communication technology, the sensors log in-transit temperature data of sensitive shipments and power DHL’s key temperature-controlled products, which includes DHL Air Thermonet and DHL Ocean Thermonet for air and sea freight respectively. The sensors can operate between -40˚C and +60°C, providing a reliable service for a large swathe of pharmaceutical products.
“We understand the challenges and sensitivities that come with transporting temperature-controlled products,” says Patricia Cole, global head at DHL Temperature Management Solutions. “The new DHL SmartSensors are part of the need to provide a holistic range of patient-centric solutions and deliver them in a safe and timely manner. We ensure that our customers’ medical products will be treated with the utmost care, as we understand what is at stake – a life that will be improved or in some cases even saved.”
“We have used this alternative temperature-controlled method with various large pharmaceutical customers,” adds Gonsowski. “Through our extensive expertise handling temperature sensitive pharmaceutical products, we follow all necessary good distribution practices and monitor shipments at all times for any temperature excursions.”
These new technologies and solutions follow the recent launch of myDHLi Quote & Book, a convenient online service for comparing quotations and making instant bookings for air, ocean freight and even door-to-door shipments. DHL’s portfolio for the healthcare industry includes expert guidance and services from pharmacists, clinical trials depots, certified stations, GDP-qualified warehouses, GMP-certified sites, medical express sites and a time-definite international express network covering 220 countries and territories.
[post_title] => DHL: The digital drugstore
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_name] => dhl-the-digital-drugstore
[post_modified] => 2019-07-04 14:49:04
[post_modified_gmt] => 2019-07-04 13:49:04
[post_parent] => 0
[guid] => https://www.hcblive.com/?p=11202
[menu_order] => 0
[post_type] => post
[comment_count] => 0
[filter] => raw